Long-Term Economic Impact of Iatrogenic Ureteral Injury in the US

Emily Shortridge,Tomomi Kimura,Qi Feng,Baoguo Jiang,Wei Han,Steven D. McCarus

DOI: https://doi.org/10.1097/01.xcs.0000896048.51376.61

2022-01-01

Journal of the American College of Surgeons

Abstract:Introduction: Iatrogenic ureteral injuries (IUI) are rare, serious complication that can occur during abdominopelvic surgeries, and may delay recovery; however, data on long-term healthcare use and cost attributable to IUI for patients and payers are limited. Methods: A retrospective observational study of the PharMetrics Plus claims database included US patients with IUI within 30 days of an abdominopelvic surgery between Jan 2016 - Dec 2018. Patients were followed for a year from the (index) surgery date. IUI patients were matched to those without, and attributable visits/cost to IUI were estimated as differences between matched pairs. Results: In total 542 IUI (median 49 years old, 80% female) and 359,221 non-IUI patients with pre-specified abdominopelvic surgeries were identified. Patients with IUI were more likely to have malignancy, diverticulitis, perforation, or endometriosis at baseline. Most (86.7%) IUIs were identified on the day of surgery. 515 IUI patients were matched to 1,545 patients without IUI. The number of annual healthcare visits was slightly higher in the IUI group, including a 12.9% higher 30-day readmission rate. Annual IUI attributable cost for patients were $374 [95% CI: -965 - 1,712] and $35,934 [26,269 - 45,599] for payers. The following CPT code ranges were most frequently associated with IUI: “Colon Resection Procedures” (15.3%), “Laparoscopic Procedures of the Abdomen/Peritoneum/Omentum” (14.2%), and “Abdominal hysterectomy” (13.8%). Conclusion: Annual healthcare visits were slightly higher among patients with IUIs, including readmission within 30 days. IUI attributable cost for patients were small, and payer’s cost were greater, driven by inpatient visits.